Hi Gamal,

I read the news of it's application for IND in US for clinical trial a decade ago, but never heard of the result of it. I did see a clinical trial safety data:

http://www.apocpcontrol.org/paper_file/issue_abs/Volume13_No10/5319-21%209.11%20Yi-Ping%20Zhan.pdf

but haven't seen any efficiency data yet. In fact, in China, most of the herbs used in combination (not the extracted single component) to treat disease, and it's also kind of personalized, each patient with the same disease may have different herb regimens. And some patients there do see both kind of physicians, they get chemo from western-training physician, and get herb treatment from TCM doctors. It's tough to track it systematically.